-
Adalimumab, sold
under the
brand name
Humira and others, is a disease-modifying
antirheumatic drug and
monoclonal antibody used to
treat rheumatoid arthritis...
-
superior to
adalimumab for ACR50, DAS28CRP≤3.2, ΔPain and ΔHAQDI. At w**** 26, more parti****nts on
upadacitinib vs
placebo or
adalimumab achieved low...
-
Based on
studies in AS, the
results suggest infliximab, etanercept, and
adalimumab have the
potential to
reduce the
signs and
symptoms of
moderate to severely...
-
comparing it with
adalimumab (Humira) and
ustekinumab (Stelara). The
safety and
efficacy of
guselkumab was
compared to a
placebo and to
adalimumab in the "VOYAGE...
-
effects can be
achieved with a
monoclonal antibody such as infliximab,
adalimumab,
certolizumab pegol, and golimumab, or with a
circulating receptor fusion...
-
azathioprine and antibodies,
including mepolizumab, omalizumab, infliximab, and
adalimumab. The word
enteritis (/ˌɛntəˈraɪtɪs/) uses
combining forms of entero- and...
-
comprising four
clinical trials which compared risankizumab to ustekinumab,
adalimumab and
placebo in the
indication of
plaque psoriasis. The
results of these...
-
proceeding with this at present."
Biosimilars available in
Australia include adalimumab, bevacizumab, enoxaparin,
epoetin lambda, etanercept, filgrastim, follitropin...
- azathioprine, methotrexate, etanercept, anakinra, tocilizumab, cyclophosphamide,
adalimumab, rituximab, and infliximab.
Newer medications target interleukin-1 (IL-1)...
-
circulating receptor such as
infliximab (Remicade),
etanercept (Enbrel), or
adalimumab (Humira) that
binds to TNF-α,
preventing it from
inducing the synthesis...
